Efficacy of Caraway Oil Poultices in Treating Irritable Bowel Syndrome - A Randomized Controlled Cross-Over Trial

Publisher： Karger

E-ISSN： 1421-9867|92|1|22-31

ISSN： 0012-2823

Source： Digestion, Vol.92, Iss.1, 2015-06, pp. : 22-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial

By Trolle B.   Flyvbjerg A.   Kesmodel U.   Lauszus F.F.  

Human Reproduction, Vol. 22, Iss. 11, 2007-11 ,pp. : 2967-2973

Oxford University Press

Access to resources Recommend Favorite

Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: A randomized, placebo-controlled, double-blind clinical trial

By Brinkhaus Benno   Hentschel Christian   Keudell Christoph Von   Schindler Gernot   Lindner Martin   Stützer Hartmut   Kohnen Ralf   Willich Stefan   Lehmacher Walter   Hahn Eckhart G.  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 8, 2005-08 ,pp. : 936-943

Informa Healthcare

Access to resources Recommend Favorite

Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial

By Søøndergaard Bo   Olsson Johan   Ohlson Kajsa   Svensson Ulla   Bytzer Peter   Ekesbo Rickard  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 6, 2011-06 ,pp. : 663-672

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

By Matsueda Kei   Harasawa Shigeru   Hongo Michio   Hiwatashi Nobuo   Sasaki Daisuke  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 10, 2008-01 ,pp. : 1202-1211

Informa Healthcare

Access to resources Recommend Favorite